Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 9Rectal Neoplasms 4Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Diabetes Mellitus, Insulin-Dependent, 12 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma 1Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Neoplasms 1Microsatellite Stable Rectal Carcinoma 1Melanoma 1Lymphoma 1Hemangiosarcoma 1Gliosarcoma 1Glioblastoma 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Advanced Renal Cell Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

balstilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Microsatellite Stable Rectal Carcinoma × balstilimab × Clear all
NCT06843434 2026-05-05

A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Microsatellite Stable Rectal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡